These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3054231)

  • 1. Predictability of a standardized captopril-test in hypertension in end-stage renal failure.
    Schohn DC; Jahn HA; Schmitt RL
    Kidney Int Suppl; 1988 Sep; 25():S145-8. PubMed ID: 3054231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Captopril--an inhibitor of the angiotensin I converting enzyme--in the treatment of arterial hypertension in chronic kidney failure patients].
    Manasia M; Paţiu IM; Vlăduţiu D; Madi A; Barabas E; Gherman M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(3):217-22. PubMed ID: 2865784
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Converting enzyme inhibitors in preterminal renal failure].
    Rambausek MH; Ritz E
    Dtsch Med Wochenschr; 1992 Jan; 117(2):77. PubMed ID: 1730207
    [No Abstract]   [Full Text] [Related]  

  • 5. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P; Zuccalà A; Gaggi R
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
    Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy.
    Zoccali C
    J Nephrol; 2002; 15(2):199-201. PubMed ID: 12018640
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of captopril therapy of arterial hypertension in children with terminal renal failure].
    Gura C; Sieniawska M; Welc-Dobies J
    Pediatr Pol; 1985 Feb; 60(2):177-85. PubMed ID: 3895149
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic possibilities of captopril in arterial hypertension in the terminal stage of chronic renal failure in recipients of a cadaveric kidney].
    Akopian AS; Migalina LA; Mishiev VG
    Urol Nefrol (Mosk); 1988; (1):49-55. PubMed ID: 3284137
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of enalapril on renal function in patients with severe chronic kidney disease.
    Vernaglione L
    Nephrol Dial Transplant; 2007 Feb; 22(2):665-6. PubMed ID: 16951420
    [No Abstract]   [Full Text] [Related]  

  • 20. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.